Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Prostatic electrovaporization, a new treatment for prostatic hyperplasia]

A Santos García-Vaquero1, J A Chicharro Molero, M Ruíz Roldán

  • 1Servicio de Urología, Hospital Regional, Málaga.

Actas Urologicas Espanolas
|July 1, 1997
PubMed
Summary

Prostate electrovaporization offers a less invasive surgical option for benign prostatic hyperplasia (BPH). This technique shows promising results with reduced recovery time and costs compared to traditional transurethral resection (TUR).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Clinical and urologic management].

Actas urologicas espanolas·2003
Same author

[Epidemiology of benign prostatic hyperplasia. Definition of the condition].

Revista clinica espanola·2000
Same author

[Analysis of the clinical decision in the initial management of BPH].

Actas urologicas espanolas·1998
Same author

[Cost-effectiveness comparative study of ceftriaxone verus cefotaxime in the treatment of complicated urinary infections].

Actas urologicas espanolas·1997
Same author

[Female stress urinary incontinence. Treatment with collagen infiltration in the urethra].

Archivos espanoles de urologia·1997
Same author

[LXI Santander National Urology Congress 1996. Clinical decision in urology. Is it measurable?].

Actas urologicas espanolas·1997

Area of Science:

  • Urology
  • Minimally Invasive Surgery
  • Surgical Technology

Background:

  • Transurethral resection (TUR) is the standard surgical treatment for benign prostatic hyperplasia (BPH).
  • While effective, TUR is associated with significant patient morbidity.
  • Newer techniques, particularly laser procedures, aim to reduce surgical complications.

Purpose of the Study:

  • To evaluate the preliminary outcomes of prostate electrovaporization for BPH management.
  • To assess the efficacy and safety of electrovaporization compared to conventional TUR.
  • To determine the feasibility and potential benefits of this novel technique.

Main Methods:

  • A prospective study involving 75 patients undergoing prostate electrovaporization over a 5-month period.

Related Experiment Videos

  • Efficacy was measured using the International Prostate Symptom Score (IPSS) and peak flow rate.
  • Safety was assessed by monitoring complications, vesical catheter duration, and operating time.

    • Main Results:

    • Mean hospital stay was 2 days, with an average operative time of 32 minutes.
    • Post-operative vesical catheterization averaged 48 hours.
    • At 3 months, patients showed a mean peak flow of 19.2 ml/sec and a mean IPSS of 7.

    Conclusions:

    • Prostate electrovaporization demonstrates a favorable preliminary safety and efficacy profile for BPH.
    • The technique offers advantages such as quick convalescence, reduced costs, and ease of performance.
    • Electrovaporization is a potential alternative to conventional TUR, warranting further long-term studies on histological effects.